BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1752956)

  • 1. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.
    Gregory TJ; Longmore WJ; Moxley MA; Whitsett JA; Reed CR; Fowler AA; Hudson LD; Maunder RJ; Crim C; Hyers TM
    J Clin Invest; 1991 Dec; 88(6):1976-81. PubMed ID: 1752956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
    Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
    Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
    Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
    Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition and function of pulmonary surfactant in adult respiratory distress syndrome.
    Hallman M; Maasilta P; Sipilä I; Tahvanainen J
    Eur Respir J Suppl; 1989 Mar; 3():104s-108s. PubMed ID: 2662993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
    Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
    Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
    Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin.
    Bernhard W; Haagsman HP; Tschernig T; Poets CF; Postle AD; van Eijk ME; von der Hardt H
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):41-50. PubMed ID: 9224208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.
    Veldhuizen RA; McCaig LA; Akino T; Lewis JF
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1867-71. PubMed ID: 8520748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
    Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
    Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha alters phospholipid content in the bronchoalveolar lavage-accessible space of isolated perfused rat lungs.
    Hertzog JH; Godinez MH; Godinez RI
    Crit Care Med; 1994 Dec; 22(12):1969-75. PubMed ID: 7988135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid.
    Schmidt R; Steinhilber W; Ruppert C; Daum C; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2002 Feb; 165(4):470-4. PubMed ID: 11850338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
    Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
    Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media inhibit exogenous surfactant therapy in rats with acute respiratory distress syndrome.
    Kesecioglu J; Haitsma JJ; Schultz MJ; den Heeten GJ; Lachmann B
    Clin Physiol Funct Imaging; 2006 Mar; 26(2):120-6. PubMed ID: 16494603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome.
    Wittkowski H; Sturrock A; van Zoelen MA; Viemann D; van der Poll T; Hoidal JR; Roth J; Foell D
    Crit Care Med; 2007 May; 35(5):1369-75. PubMed ID: 17414728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant abnormalities in patients with respiratory failure after multiple trauma.
    Pison U; Seeger W; Buchhorn R; Joka T; Brand M; Obertacke U; Neuhof H; Schmit-Neuerburg KP
    Am Rev Respir Dis; 1989 Oct; 140(4):1033-9. PubMed ID: 2802366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome.
    Danlois F; Zaltash S; Johansson J; Robertson B; Haagsman HP; van Eijk M; Beers MF; Rollin F; Ruysschaert JM; Vandenbussche G
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):779-87. PubMed ID: 11042134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
    Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways.
    Chandel NS; Budinger GR; Mutlu GM; Varga J; Synenki L; Donnelly HK; Zirk A; Eisenbart J; Jovanovic B; Jain M
    Crit Care Med; 2009 May; 37(5):1678-84. PubMed ID: 19325470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
    McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ
    Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.